Richard Feinstein

Federal Trade Commission

Guest

Richard Feinstein on KCRW

Patents are about to expire on two of the world's best-selling prescription drugs.

Expiring Patents, Drug Prices and the Hazy Market for Generics

Patents are about to expire on two of the world's best-selling prescription drugs.

from To the Point

More from KCRW

What can we expect if RFK Jr. becomes health secretary? Will Trump take action on Dreamers? Plus, KCRW analyzes how progressives influenced the Democratic mandate.

from Left, Right & Center

Amidst the hype, excitement and nervousness of the election, the bigger picture of what the United States is and how it operates often gets lost on people.

from Scheer Intelligence

The final campaign days are here. How are early voters affecting candidate strategies? Plus, the panel discusses how abortion rights may change the Nevada battleground.

from Left, Right & Center

KCRW examines Donald Trump’s cabinet picks. Is the GOP misreading an immigration “mandate” from voters? Plus, is America just not ready for a woman president?

from Left, Right & Center

The Irvine Police Department purchased a Tesla Cybertruck to promote its D.A.R.E drug program. But some taxpayers say the money should be spent elsewhere.

from KCRW Features

Prop 34 – sponsored by the California Apartment Association – looks like health care reform, but it’s crafted to stop one nonprofit from spending on politics.

from KCRW Features

Will Donald Trump reduce U.S. interventionism? Did President Biden open a can of worms by pardoning his son Hunter? Plus, KCRW looks at what justice means post-election.

from Left, Right & Center

Little Saigon’s Vietnamese community has long leaned Republican. Now local Democrat Derek Tran is trying to peel away votes in an OC swing district.

from KCRW Features

Does “working class” mean what it used to? Is fracking getting more attention than it deserves? Plus, KCRW examines what came out of one culture war in Lancaster, Pennsylvania.

from Left, Right & Center